Results 191 to 200 of about 160,386 (240)

Leading and lagging strand abasic sites differentially affect vertebrate replisome progression but involve analogous bypass mechanisms. [PDF]

Nucleic Acids Res
Cranford MT, Dahmen SN, Cortez D, Dewar JM.   +3 more
europepmc   +1 more source

Tau PET overlap index correlation with neuropathological findings. [PDF]

Alzheimers Dement
Lim S, Lee J, Min PH, Moloney CM, Mester CT, Ghatamaneni S, Senjem ML, Botha H, Knopman DS, McCarter SJ, Ramanan VK, Savica R, Fields JA, Machulda MM, Dickson DW, Reichard RR, Nguyen AT, Graff-Radford J, Schwarz CG, Gunter JL, Kantarci K, Boeve B, Vemuri P, Jones DT, Jack CR, Petersen RC, Murray ME, Lowe VJ.   +27 more
europepmc   +1 more source

Development of Novel ¹⁸F‑Labeled Selective Orexin‑2 Receptor Radioligands for Positron Emission Tomography. [PDF]

ACS Pharmacol Transl Sci
Rong J, Zhao C, Chaudhary AF, Chen J, Li Y, Zhou X, Song Z, Sun Z, Gao Y, Feng S, Zhao T, Hu QL, Li C, Patel J, Yuan H, Haider A, Liang SH.   +16 more
europepmc   +1 more source

Development of [¹⁸F]ACI-19626 as a first-in-class brain PET tracer for imaging TDP-43 pathology. [PDF]

Nat Commun
Vokali E, Chevalier E, Dreyfus N, Charmey D, Melly T, Kocher J, Ratnam M, Serra AM, Jaquier T, Delgado C, Ravache M, Scialò C, Cappelli S, Kroth H, Capotosti F, Luthi-Carter R, Afroz T, Derouazi M, Constantinescu CC, Seelaar H, Buratti E, Nelson PT, Polymenidou M, Pfeifer A, Kosco-Vilbois M, Seredenina T.   +25 more
europepmc   +1 more source

Preclinical evaluation of DOTAGA.Glu.(FAPI)₂ and DO3A.Glu.(FAPI)₂ as theranostics with human dosimetry extrapolation to lutetium-177 and terbium-161 analogs. [PDF]

Eur J Nucl Med Mol Imaging
Bilinska A, Kumar N, Gnesin S, Läppchen T, Menéndez E, Martin M, Rösch F, Rominger A, Gourni E.   +8 more
europepmc   +1 more source

Radiolabeled <i>para</i>-I-nimesulide: an unexpected tracer for imaging peripheral inflammation. [PDF]

Front Nucl Med
Yamamoto Y, Imai K, Saito Y, Yamamoto F.
europepmc   +1 more source

Increased levels of GFAP and purinergic P2X7 receptor in Alzheimer's disease brain are associated with Aβ, tau pathologies and synaptic loss. [PDF]

Alzheimers Res Ther
Maschio CA, Moreno O, Wang J, Maheshwari U, Keller A, Konietzko U, Razansky D, Nordberg A, Rominger A, Hock C, Llop J, Nitsch RM, Ni R.   +12 more
europepmc   +1 more source

Preclinical development of [¹⁸F]TAAR1-2203 as a PET radioligand for imaging TAAR1 expression and receptor occupancy. [PDF]

Eur J Nucl Med Mol Imaging
Haider A, Xiao Z, Chen J, Pfister SK, Zhou X, Li Y, Chaudhary A, Zhao C, Rong J, Paehler A, Mohr S, Norcross RD, Honer M, Mu L, Gobbi L, Schibli R, Hoener MC, Liang SH.   +17 more
europepmc   +1 more source

Quantitative dynamic granzyme B PET imaging to characterize novel combination immunotherapy response in preclinical glioblastoma models. [PDF]

Theranostics
Gallegos CA, Lu Y, Song PN, Queiroz R, Akca U, Sridhar S, Bartels JL, Zhang Y, Li L, Warram JM, Lapi SE, Larimer BM, Markert JM, Sorace AG.   +13 more
europepmc   +1 more source

Development and In Vitro Characterization of [³H]GMC-058 as Radioligand for Imaging Parkinsonian-Related Proteinopathies. [PDF]

Cells
Varrone A, Sousa VC, Mugnaini M, Biesinger S, Nordvall G, Kingston L, Guzzetti I, Elmore CS, Sunnemark D, Saturnino Guarino D, Finnema SJ, Schou M.   +11 more
europepmc   +1 more source